Navigation Links
PROLOR Biotech To Present Preclinical Data On Its Long-Acting Clotting Factor Vlla At 2012 ASH Annual Meeting
Date:12/7/2012

ATLANTA and NES-ZIONA, Israel, Dec. 7, 2012 /PRNewswire/ -- PROLOR Biotech, Inc. (NYSE MKT: PBTH), today announced that the company will present preclinical data on its long-acting clotting Factor VIIa (Factor Vlla-CTP) at the 54th Annual Meeting of the American Society of Hematology (ASH).  The data will be discussed by Dr. Gili Hart, Director of Pre-Clinical Affairs at PROLOR and head of the company's long-acting clotting factors program, in an oral poster presentation on December 8, 2012.  PROLOR's Factor VIIa-CTP is in advanced preclinical development for the treatment of hemophilia.

Top-line results of the Factor Vlla-CTP studies have been previously reported by PROLOR. The results show that when compared to commercially available Factor VIIa, Factor VIIa-CTP in hemophilic mice demonstrated a markedly enhanced pharmacokinetic profile and increased exposure, as evidenced by a prolonged hemostatic effect and improved recovery, which is a measure of clotting activity.  Compared to commercially available Factor VIIa, Factor VIIa-CTP in hemophilic mice demonstrated superior thrombin generation parameters, and it resulted in greater survival of the subjects.  In these studies, the specific activity of Factor VIIa-CTP was comparable to commercial Factor VIIa.  The study data also show that administration of Factor Vlla-CTP by subcutaneous injection resulted in improved bioavailability and prolonged exposure compared to intravenous administration of Factor Vlla-CTP.

PROLOR CEO Dr. Abraham Havron commented, "The ASH Annual Meeting is the largest and most prominent gathering of hematology experts in the world.  In preclinical studies our long-acting clotting factors have demonstrated the potential to significantly improve both the prophylactic and on-demand treatment of patients with hemophilia, and we welcome the opportunity to share these promising data with leading hematology researchers."

Dr. Hart will presen
'/>"/>

SOURCE PROLOR Biotech, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GenWay Biotech Appoints New Vice President of Custom/OEM
2. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
3. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
4. Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis
5. TaiGen Biotechnology Out-Licensed China Rights of Novel Antibiotic, Nemonoxacin, to Zhejiang Medicine
6. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
7. Obamacare Ruling, Other Pivotal News Rocks Biotech Sector in June
8. Tougher Times May be Ahead for Biotechs: 1H12 Fundraising Slows
9. Last Chance to Save on Boston-Area Mobile Health, Biotech, and Pharmaceutical Conference Registration
10. Early Birds Save Up to $600 on Asian Biotech and Pharmaceutical Conferences
11. Lifeline Biotechnologies First Warning Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Today, UBM China, a wholly owned subsidiary ... Tianyi Exhibition Co., Ltd. to jointly run the Health ... held concurrently with CWMEE 2016. This ... following MEDTEC China and DENTECH China, and fills its ... It,s also another concrete cooperative project in ...
(Date:6/30/2015)...  July 4 th is this weekend, a time ... and people behind it. To help honor our current nation,s ... USA Medical Card, a leading provider of free ... empower independence for our disabled military veterans, police, firemen, and ... their prescriptions. "Due to USA ...
(Date:6/30/2015)... 30, 2015  Marken, the leading clinical trial logistics ... industry, has been granted permission by the government to ... drug product in Korea.  This precedent-setting shipment has allowed ... to continue receiving their clinical trial drugs during the ... The emergency was caused by recent partial closures of ...
Breaking Medicine Technology:UBM Joins Chengdu Tianyi to Hold CWMEE 2016 2UBM Joins Chengdu Tianyi to Hold CWMEE 2016 3Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Marken Delivers Direct To Patients During MERS Outbreak 2Marken Delivers Direct To Patients During MERS Outbreak 3
... , an industry-leading vendor of ambulatory healthcare software ... fastest-growing private companies in America. ... http://www.newscom.com/cgi-bin/prnh/20100817/INC5000LOGO ) The listing was published ... an exclusive compilation of the nation,s fastest-growing private ...
... 26 Wound Management Technologies, Inc. (OTC Bulletin Board: ... Wound Care Innovations, LLC has further expanded its rapidly ... the addition of Central Medical Systems to its already ... CMSI is the ideal type of distributor; they have ...
Cached Medicine Technology:Pulse Makes the 2010 Inc. 5000 List of the Fastest-Growing Private Companies in America 2Wound Management Technologies Expands Distribution Foot Print in Florida with the Addition of Central Medical Systems 2Wound Management Technologies Expands Distribution Foot Print in Florida with the Addition of Central Medical Systems 3
(Date:6/30/2015)... ... June 30, 2015 , ... The campaign aims to make ... the different forms of digestive disorders over 70 million Americans face and inspiring readers ... system in tip-top shape. , The print component of “Digestive Wellness” is distributed within ...
(Date:6/30/2015)... ... June 30, 2015 , ... Experts estimate that up to ... Back pain can range from a dull, constant ache (chronic) to a sudden sharp ... epidural steroid injections, selective nerve root blocks and rhizotomy treatment, OPTIMAL Pain & ...
(Date:6/30/2015)... ... , ... It has become fairly common to purchase fresh broccoli at the ... before cooking. Throwing out radish greens, beet leaves and chard stalks is pretty typical, ... takes a little knowledge and practice to use them. Josie's Organics is ...
(Date:6/30/2015)... ... June 30, 2015 , ... New ... expedited through the use of new forms, according to attorneys handling Xarelto ... and the Short Form Complaint, “provide guidance” for plaintiffs’ attorneys in filing new ...
(Date:6/30/2015)... ... 2015 , ... When it comes to volunteering abroad, not many people end ... be too high. However, there are affordable programs to be had such as those ... cost. One such volunteer named Uzma Aishah, a student at the International Medical University ...
Breaking Medicine News(10 mins):Health News:Mediaplanet’s “Digestive Wellness” Campaign Urges You To Listen to What Your Stomach Is Telling You and Talk About It 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 3Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 2Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 3Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 4Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 2Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 3Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 2Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 3
... have worse physical and life-quality outcomes and slower recovery ... ,Orthopaedic injury, usually from transport accidents or ... Australia, according to the study published in the latest ... Professor Peter Cameron, Head of the Emergency and Trauma ...
... screening test for cervical cancer detects more abnormalities than ... published on bmj.com today. ,It could also ... might allow for longer intervals in-between testing, says Elizabeth ... conventional pap smears for cervical cancer has been around ...
... campaign may be on to list Taj Mahal in the ... enveloped in a haze of dust and smog. ... eventually turn the gleaming white Taj Mahal black, have raised ... historian with Agra University, says the Taj needs corrective treatment ...
... Inc. announced today that it has dosed its ... (Study 201) of ALT-2074, its lead glutathione peroxidase mimetic, ... that renders them at high risk for cardiovascular complications. ... to evaluate ALT-2074's ability to lower inflammatory cardiovascular biomarkers ...
... Board: AVGO), a late stage biotechnology company that develops ... the selection of the optimal dose of HD-02, ... Disease. ,This dose was determined in an ... and Dr. Diana Rosas of Massachusetts General Hospital (MGH), ...
... have found that Exercise has a similar effect to ... ,In a series of scientific reports, she ... why exercise can be a form of therapy for ... with an SSRI drug. ,The experiment studies ...
Cached Medicine News:Health News:New Cervical Cancer Test Increases the Detection Rate of Abnormal Cells 2Health News:Alteon Initiates Phase 2 Trial of ALT-2074 in Diabetes and Haptoglobin 2-2 2Health News:Avicena to Advance Huntington's Disease Clinical Program into Phase III 2
For the quantitative determination of Glycohemoglobin in blood....
The BioCheck Ferritin ELISA is intended for the quantitative determination of ferritin in human serum. This assay is to be used in the diagnosis of diseases affecting iron metabolism....
Rapid turn-around time, results in less than 4 hours...
... Bio-Rad isotopic anemia assays ... minimal ,pipetting steps for ... about the processes ,involved ... the benefit to your ...
Medicine Products: